Thyroid function and deiodinase activities in rats with marginal iodine deficiency by Janssen, K.P.L.T.M.K. (Karin) et al.
9 1994 by Humana Press Inc. 
All fights of any nature, whatsoever, reserved. 
0163-4984/94/40-030237 $0 .00 
Thyroid Function and Deiodinase 
Activities in Rats with Marginal 
Iodine Deficiency 
KARIN P. L. T. M. K. JANSSEN, L DAAN VAN DER HEIDE, t" 
THEO J .  VISSER, 2 ELLEN KAPTEIN, 2 AND ANTON C. BEYNEN 3 
Department of Human and Animal Physiology, Agricultural University, 
Haanveg I0, 6709 P J, Wageningen, The Netherlands; Department of 
Internal/qedicine 1II, Erasmus University NedJcal School, Rotterdam; 
-~Depar~nent of Large Animal Medicine and NutrN'on, Faculty of 
Veterinary Medicine, State University, Utrecht, The Netherlands 
Received April 2, 1993; Revised June 30, 1993; Accepted July 18, 1993 
ABSTRACT 
The hypothesis tested was whether marginal iodine deficiency 
for a period of 6 wk affects iodothyronine deiodinase activities in liver 
and brain of rats. Male rats were fed purified diets either defident or 
sufficient in iodine; the diets were fed on a restricted basis (60% of ad 
libitum intake). Body weight gain of the two groups was comparable, 
Iodine deficiency was evidenced by increased thyroid weight (26%), 
reduced urinary iodine excretion (80%), and reduced plasma T4 con- 
centrations (22%). Activities of liver type I and brain type III de- 
iodinase were unchanged, but the activity of type I] deiodinase in 
brain was increased (28%) in the iodine-deficient rats. Food restriction 
per se significantly lowered T 3 (30%) and I"4 (22%) concentrations in
plasma and decreased type III deiodinase activity in brain (30%). 
These results indicate that in marginal iodine deficiency the activities 
of hepatic type I deiodinase and brain type III deiodinase are un- 
changed, whereas that of brain type II deiodinase is increased. 
Index Entries: Rats; iodine deficiency; food restriction; thyroid; 
deiodination; liver; brain. 
*Author to whom all correspondence and reprint requests should be addressed. 
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Abbreviations: DTT = dithiotreithol; Hepes = N-[2-hydroxy- 
ethyl]piperazine-N'-[2-ethanesulfonic acid]; PTU = propylthioura- 
cil; I = iodine; rT3 = reverse  T 3 = 3,Y,5'-triiodothyronine; 3,3'-T2 = 
3,3 ' -d i iodothyron ine ;  T 3 = 3,Y,5-triiodothyronine; T4 = 3,3',5,5'- 
tetra-iodothyronine; TS[-I = thyroid stimulating hormone; IRD = 
inner ring deiodination; ORD = outer ring deiodination. 
INTRODUCTION 
Cretinism and goiter are often caused by iodine deficiency (1-3). 
Iodine deficiency is associated with slightly elevated TSH, decreased T4, 
and normal or slightly elevated T 3 levels in plasma (4). Hypothyroidism 
is characterized by high TSH, low T4, and low T3 levels in plasma (5,6). 
In rats with hypothyroidism there is a marked decrease in type I 
iodothyronine deiodinase activity in liver (7,8). A decrease in type IlI 
deiodination has also been found in brains of hypothyroid rats (9,10). 
However, the activity of brain type 11 deiodinase is enhanced in hypo- 
thyroidism (8-10). 
The type I enzyme, mainly present in liver, kidney, and thyroid, 
catalyzes the deiodination of the outer and/or inner ring of different 
iodothyronines and is very important for the production of plasma T3; it 
is most efficient in outer ring deiodination (ORD) of rT 3. Type II de- 
iodinase only catalyzes ORD of T 4 to T 3 and rT 3 to 3,3'-T 2 and is impor- 
tant for the local production of T 3 in tissues such as brain. Type III 
deiodinase inactivates T4 and T3 by inner ring deiodination (IRD) and 
probably is important for the clearance of plasma T 3 (7). 
The abovementioned studies with rats with severe hypothyroidism 
may not be relevant for the situation in humans in areas where mod- 
erately reduced intake is a problem. Therefore, we have induced in rats a 
marginal iodine deficiency that is not associated with growth retardation 
or other clinical signs. Using this animal model we determined the 
activities of type I deiodinase in liver homogenates and those of type II 
and III deiodinases in brain homogenates. 
MATERIALS ArID METHODS 
The experimental protocol was approved and its execution super- 
vised by the animal welfare officer of the Wageningen Agricultural Uni- 
versity. 
Animals and Housing 
Male, 30-d-old Wistar rats (Cpb/Hsd; Harlan Inc, Zeist, The Nether- 
lands) were used. During the pre-experimental period of 2 wk (d-14-0), 
the rats were housed in groups of six animals in stainless-steel cages (60 
x 42 • 19 cm) with wire mesh bases. During the experimental period of 
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6 wk (d 0-42) they were kept individually in metabolic ages (314 cm 2 x 
15 cm). The cages were placed in a room with controlled temperature 
(20-22~ relative humidity (45-65%), and a 12-h light-dark cycle (lights 
on: 7 AM to 7 PM). 
Diets and Feeding 
The diets were in powdered form and stored at 4~ until feeding. 
During the pre-experimental period, all rats were fed a purified control 
diet and twice-distilled water ad libitum. The control diet was iodine- 
sufficient (1.2 ~xmol added iodine/kg) and its composition was as follows: 
ovalbumin, 15l g; corn oil, 25 g; coconut fat, 25 g; glucose, 709.4 g; 
cellulose, 30 g; CaCO3, 12.4 g; NaH2PO4-2H20, 15.1 g; MgCO 3, 1.4 g; 
KCI, 1.0 g; KHCO3, 7.7 g; KIO3, 0.25 mg; iodine-flee mineral premix, 10 
g; vitamin premix, 12 g. The mineral premix consisted of (mg): MnO2, 79; 
NaF, 2; NH.tVO3, 0.2; FeSO4"7H20, 174; NiSO4.6H20, 13; ZnSO4-H20, 33; 
CuSO4-5H20, 15.7; SnC12.2H20, 1.9; Na2SeOy5H20, 0.3; CrC13"6H20, 1.5; 
corn meal, 9679.4. The vitamin premix consisted of (mg): thiamin, 4; 
riboflavin, 3; pyridoxine, 6; niacinamide, 20; D,t.-calcium pantothenate, 
17.8; folic acid, 1; biotin, 2; cyanocobalamine, 50;choline chloride, 2000; 
D,L-a-tocopheryl acetate, 60; menadione, 0.05; retinyl acetate and retinyl 
palmitate, 8 (1200 retinol equivalents); cholecalciferol, 0.025; corn meal, 
9828.125. 
At the end of the Ere-experimental period (d 0), the rats were 
divided into three groups, which were stratified for body weight. One 
group of 12 rats and one group of 6 rats remained on the control diet. The 
other group of 12 rats received an iodine-deficient diet. To prepare the 
iodine-deficient diet, KtO3 was omitted from the control diet. The group 
of 6 rats was fed ad libitum. The other two groups received 60% of ad 
libitum intake; with this feeding regimen any difference in feed intake 
and growth rate between these groups would be precluded. Food was 
administered daily. Twice distilled water was freely available. 
Experimental Procedures 
Body weight was measured once a week. Food intake was measured 
daily. During the last 3 d of the experiment (d 39--42) urine was collected 
quantitatively from each rat and stored at --20~ until analysis. At the 
end of the experiment (d 42), the rats were anesthetized with diethyl 
ether and blood samples were collected in heparinized tubes by aorta 
puncture. The anesthetized rats were killed subsequently b  CO2 inhala- 
t-ion. Organs were removed and weights determined immediately. Plas- 
ma was stored at - 20~ until analysis. Brains and livers were collected in 
liquid nitrogen and stored at -80~ until analysis. 
Urinary iodine and creatinine were determined as described by 
Kolthoff and Sandell (11) and by Folin (12), respectively. Plasma T 3 and 
T 4 were analyzed by radioimmunoassays without prior extraction accord- 
Biological Trace Element Research Vol. 40, 1994 
240 Janssen et aL 
ing to the method of Larsen (13), with minor modifications a  described 
by Van Hardeveld and Kassenaar (14). 
To prepare liver homogenates, a portion of the liver was weighed 
and homogenized in 10 volumes of ice-cold buffer A (10 mM Hepes, 
0.25M sucrose and I0 mM DTT, pH 7). Brains (cerebral cortex, striatum, 
and midbrain) were homogenized in 5 vol of ice-cold buffer A. Homoge- 
hates were stored at -70~ until analysis. Protein content of tissue 
homogenates were measured with the Bio-Rad protein assay (Pierce 
Europe, Oud Beijerland, The Netherlands) using bovine serum albumin 
as standard. 
All deiodinase assays were performed in the presence of DTT by 
analysis of radioiodide production from 12Slqabeled substrates, imilarly 
to the method of Mol et aI. (15). All deiodinase r actions were stopped by 
adding 100 ILL pooled human serum and 500 IxL ice-cold 10% TCA. 
Released lzsI- was separated from protein-bound iodothyronines by 
centrifugation. The data were corrected for nonenzymatic deiodination 
as determined in the absence of tissue homogenate. For calculation of 
deiodinase activities, random labeling of 3' and 5' positions of [lZSl]rT3 
and [IzSI]T4 and of the 3 and 5 positions of [12SI]T3 was taken into account. 
Hepatic type I deiodinase activity was determined by incubation of 
the appropriate amount of homogenate protein (final concentration 0.05 
mg/mL) for 20 rain at 37~ with 75 nCi [3',5'-12Sl]rT3 and 1 IxM rT3 in the 
presence of 10 mM DTF in buffer B (final concentrations: 0.1M sodium- 
phosphate, 2 mM EDTA, pH 7.2; final volume: 200 la, L). 
Type II deiodinase activity was determined by incubation with 0.5 
nM [3',5'-125I]T4 for 2 h at 37~ with brain homogenate (4 times diluted) 
in the presence of I laM T 3, 1 mM PTU, and 25 mM DTT in buffer B. PTU 
and T 3 were added to prevent possible interference bytype I and type Ill 
deiodinase. This was verified by HPLC analysis of parallel incubations 
(n = 12). Therefore the deiodinase reaction was stopped by adding 200 
IxL methanol to the incubation mixture, lodothyronine metabolites were 
analyzed using HPLC (16). Furthermore, the correlation coefficient be- 
tween [lZSl]T 3 production measured with HPLC and 1251- production 
measured according to Mol et al. (15) was 0.9067 (p = 0.001). 
Type [II deiodinase activity in brain homogenates was determined 
by incubating 5 nM [3,5-12SI]T3 (courtesy of H. Rokos, Herming, Berlin, 
FRG) for 20 min at 37~ with diluted brain homogenate (final protein 
concentration 0.5 mg/mL) in the presence of I IxM rT3, 0.1 rnM PTU and 
50 mM D'IT in 200 IxL buffer B. PTU and rT 3 were added to block possible 
type I deiodination of the labeled T 3. 
,Stat/st/cs 
Data were analyzed using the Statistical Package for Social Sciences 
(SPSS) (17). The level of significance was preset at p < 0.05. Data were 
checked for normality. For normally distributed ata, group means were 
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compared using a two-tailed, unpaired Student's t-test. To take into 
account he increasing risk of a type I error caused by multiple compari- 
sons, Bonferroni's adaptation of the p value was applied, leading to a 
significance l vel of p ( 0.025. Mann-Whitney U test was used to evalu- 
ate differences between group means of not normally distributed ata 
(18). 
RESULTS 
Body Weight and Organ Weights 
Initial (d 0) body weight of the rats was 138.1 + 11.8 g (mean + SD, 
n = 30). Average feed intake during the experiment by the group fed ad 
libitum was 21.8 _+ 1.6 g/d (mean :-~ SD, n = 6). Growth rates, final (d 42) 
body and organ weights of the experimental groups are shown in Table 
1. Restricting feed intake to 60% of ad libitum intake reduced body weight 
gain by about 57% (Table 1). The rats fed the restricted amount of the 
control diet also had lower absolute organ weights, t lowever, when 
expressed relative to body weight, the rats fed on a restricted basis had 
higher brain and pituitary weights, but lower liver weights. This can be 
explained by a lower degree of adiposity in the animals fed the restricted 
amount of feed. Restricted feeding of the iodine-deficient diet did not 
affect body weight, when compared with restricted feeding of the control 
diet (Table 1). 
Io~'ne Status 
Iodine deficiency significantly increased mean thyroid weight by 
26% (Table 2). Relative thyroid weight was also significantly increased 
by iodine deficiency. Restricted feeding per se decreased thyroid weight 
by on average 33%, but relative thyroid weight was unchanged. Re- 
stricted feeding did not alter the iodine:creatinine ratio in urine. The 
ratio was significantly lowered in iodine deficiency. 
Thyroid Hormones 
Restricted feed intake lowered T4 levels in plasma (Table 2). Reduced 
plasma T 4 concentrations were also observed in the iodine-deficient rats. 
Rats fed restricted amounts of the control diet had significantly lower 
mean T 3 concentrations than their counterparts fed ad libitum. T 3 concen-  
t ra t ion  was not affected by iodine deficiency. 
lodothyrordne Deiodinase Activities 
No differences between groups in protein concentration of liver and 
brain homogenates were found (Table 3). In rats fed ad libitum, specific 
activities of hepatic type I deiodinase and brain type II deiodinase were 
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Table 1 
Effects of Iodine Deficiency and/or Food Restriction on Growth, 
Body Weight, and Organ Weights 
Feeding regimen: Restricted Ad Iibitum 
Diet: Control, n = 12 I deficient, n = 12 Control, n = 6 
Mean SD Mean SD Mean SD 
Growth, g/d 2.3" 0.3 2.2 0.2 5.3 0.3 
Body weight, g 234.2" 8.8 229.0 10.3 364.0 9.0 
Liver weight, g 6.01" 0.56 5.811 0.57 14.28 1.09 
Liver weight, 
g/100 g BW 2.57" 0.24 2.53 0.20 3.92 0.27 
Brain weight, g 1.71" 0.04 1.67 0.08 1.80 0.07 
Brain weight, 
g/100 g BW 0.73" 0.02 0.73 0.05 0.50 0.03 
Weight kidneys, 
g 1.57" 0.10 1.57 0.10 2.31 0.19 
Weight kidneys, 
g/100 g BW 0.67 0.05 0.68 0.04 0.63 0.05 
Spleen weight, g 0.41" 0.03 0.40 0.03 0.60 0.07 
Spleen weight, 
g/100 g BW 0.17 0.01 0.1.7 0.02 0.17 0.02 
Pituitary weight, 
mg 7.1" 0.5 7.0 0.7 9.8 0.9 
Pituitary weight, 
rag/100 g BW 3.(Y' 0.2 3.0 0.3 2.7 0.2 
"Restricted control vs ad libitum control diet, p < 0.001. 
~'Restricted control vs ad libitum control diet, p < 0.025. 
similar to those in rats fed on a restricted basis. Type I deiodinase activity 
in whole liver had decreased by restricted feeding. Restricted feeding 
significantly lowered type IlI deiodinase activity in brain. Iodine deficien- 
cy did not affect the specific activity of type I deiodinase in liver, but 
increased group mean type II deiodinase activity in brain. The stimula- 
tory effect of iodine deficiency on brain type lI deiodinase activity did not 
reach statistical significance (p = 0.049). In a parallel experiment (un- 
published), we used diets that were identical to those in the present 
study, but without selenium (Na2SeO'5H20) added to the mineral pre- 
mix. Selenium contents of the diets were determined using two different 
methods (19,20). Analysis showed that the control diet of the present 
study contained 0.19 (19) or 0.15 (20) mg Se/kg. The analyzed selenium 
concentrations of the diets used in the present and parallel study were as 
follows: iodine sufficient diet without added selenium, 0.09 (19) or 0.07 
(20) mg Se/kg; iodine deficient diet with added selenium, 0.10 mg Se/kg; 
iodine deficient diet without added selenium, 0.09 mg Se/kg. The latter 
two diets were analyzed using the method of Koh and Benson (19) only. 
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Feeding regimen: 
Diet: 
Restricted 
Control, n = 12 I deficient, n = 12 
Mean SD Mean SD 
Ad libitum 
Control, n = 6 
Mean SD 
Urinary iodine, 
~xgl/d 3.21 1.11 0.66 r 0.20 3.90 0.97 
Urinary creatinine, 
rruVI 6.79" 2.52 6.79 3.31 12.03 2.97 
Ur ina~ iodine, 
bugI/g creatinine 290.7 11 t.4 58.3 ~ 17.5 230,6 70.9 
Thyroid weight, 
mg 17.8" 2.0 22.4 ~ 3.9 26.5 5.8 
Thyroid weight, 
mg/100 g BW 7.6 0.9 9.8 '~ 1.9 7.3 1.b 
Plasma T4, 
nM 63 b 10 4~ 8 81 9 
Plasma T~, 
nM 0.35" 0.09 0.38 0,15 0.50 0.09 
"Restricted control vs ad libitum control  diet, p < 0.001. 
~Restricted control vs ad libitum control diet, p < 0.025. 
CRestricted iodine deficient vs restricted control diet, p < 0.001. 
JRestricted iodine deficient vs restricted control diet, p < 0.025. 
Table 3 
Effect of Iodine Deficiency or Food Restriction on Deiodinase Activities 
Feeding re ,men:  Restricted Ad tibitum 
Diet: Control, n = 12 I deficient, n = 12 Control, n = 6 
Mean SD Mean SD Mean SD 
Hepatic deiodinase-I, 
pmol/mg/min 264 51 252 42 296 82 
Brain deiodinase-II, 
fmol/mg/h 4.74 1.02 6.00 1.82 3.98 0.90 
Brain deiodinase-II I  
pmol/mg/h 3.39" ' 0.50 3.43 0.32 4.82 0.69 
Protein content of 
liver homogenates,  
mg/mL 16.5 1.1 16.3 0.9 14.7 2.1 
Protein content of 
brain homogenates,  
mg/mL 14.8 0.8 15.6 1.0 14.4 1.3 
"Restricted control vs ad libitum control diet, p < 0.001. 
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The diets without added selenium used in the parallel study were also 
fed to rats at a level of 60% of ad libitum intake for a period of 42 d. Iodine 
deficiency as induced with the diets without added selenium was found 
to significantly (p = 0.001) increase brain type II deiodinase activity, the 
activities in deficient and sufficient animals being 7.3 _ 2.2 and 4.6 • 0.8 
fmol/h per mg protein (means + SD, n = 12). In that experiment type III 
deiodinase activity in brain homogenates was not affected by iodine 
deficiency. 
DISCUSSION 
At the end of the experiment, the control and iodine-deficient 
groups fed restricted amounts of feed had similar body and organ 
weights, except for the thyroid gland. As would be expected (4), iodine 
deficiency as only variable raised thyroid weight and lowered plasma T4 
concentrations. These results indicate that the iodine-deficient rats had a 
mild form of hypothyroidism, but growth rate was not affected. 
The control groups fed either ad libitum or on a restricted basis had 
similar daily excretions of iodine. Thus, the control rats fed restricted 
amounts of feed can be considered iodine sufficient; their iodine intake 
was on average 0.015 l~mol/d. Iodine intake of the rats fed the control diet 
ad libitum was on average 0.025 i*mol/d. However, this difference in 
iodine intake owing to ad libitum vs restricted feeding, did not signifi- 
cantly affect daily iodine excretion. Furthermore, the decrease in daily 
iodine excretion owing to restricted feeding, was not proportional to the 
decrease in iodine intake. It can be hypothesized that iodine excretion in 
the form of T 4 and its metabolites in feces is decreased, leading to a 
higher proportion of iodine in urine (21,22). 
Urinary iodine:creatinine ratios were determined to monitor the 
iodine status of the rats. After six weeks, the ratio was lowered by about 
80% in the rats fed the diet without added iodine when compared with 
the controls who were fed on a restricted basis. Restricted feeding low- 
ered urinary creatinine levels. A lowering effect of malnutrit ion on uri- 
nary creatinine concentration has also been reported for humans (23). 
Thus, the iodine:creatinine ratio as such may be an unreliable index to 
compare iodine status of undernour ished people with that of well- 
nour ished people. Twenty-four-hour-urinary iodine excretion is a better 
index of the iodine status in areas where malnutrition occurs. 
Iodine deficiency per se did not influence hepatic T 4 to T 3 mono- 
deiodination as based on type I deiodinase activity. Possibly, type I 
monodeiodinase activity is decreased only when circulating thyroid hor- 
mones are markedly reduced. Evidence for this notion has been pre- 
sented earlier (7,8). 
Iodine-deficient rats had an increased activity of type II deiodinase in 
brain. The activity that we found is rather low when compared with 
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other studies (8,9). This can be explained by the fact that we used 
homogenates of brain tissue consisting of cerebral cortex, striatum, and 
nfidbrain. Unlike others (9,10) we did not include cerebellum, which has 
a relatively high activity of type II deiodinase (9,10). Moreover, we used 
homogenates instead of microsomes. Our results do show that a mild 
reduction in serum T 4 is associated with an increase in apparent ype II 
deiodinase activity. Interference of type II deiodinase measurement by 
endogenous  T 4 cannot be excluded. However, it is unlikely that a change 
in endogenous T 4 in the homogenates accounts for the observed increase 
in type II deiodinase activity in iodine-deficient rats. The T 4 concentra- 
tion in the incubation mixture (endogenous plus tracer) as estimated 
according to Van Doom et al. (24) was far below the apparent K,, (1 nM) 
of the type II deiodinase (7). Furthermore, the contribution of endoge- 
nous T 4 probably is low compared to the added tracer T 4. Thus, varia- 
tions in brain T4 concentrations may not have measurably affected de- 
iodinase type II activity. 
Marginal iodine deficiency did not affect brain type III deiodinase 
activity. Studies using thyroidectomized rats with severely reduced T 4 
levels have shown decreased type III deiodinase activities (9,10). 
Food restriction lowered plasma T4 and T 3 concentrations. The de- 
creased T3 levels in plasma may limit energy expenditure during a period 
of restricted feed intake. Schr6der-van der Elst and Van der Heide (21) 
described that restricted feeding of rats lowers peripheral T3 production. 
The present results show that specific hepatic type I deiodinase was not 
reduced by food restriction. However, because of the decrease in liver 
weight, type I deiodinase activity in whole liver was decreased. The 
lowering effect of food restriction on T 3 to T z monodeiodination in brain 
can be considered as a mechanism, protecting the brain against shortage 
of T3, even in situations when Y 4 levels are decreased. 
In sum, under the present experimental conditions marginal iodine 
deficiency had predictable ffects on thyroid function. Food restriction 
alone also influenced thyroid hormone metabolism as evidenced by a fall 
of plasma T4 and T 3 levels and a significant decrease in type III de- 
iodinase activity in brain. In addition, in rats with mild hypothyroidism 
brain type II deiodinase activity was increased. Type II deiodinase in 
brain seems more sensitive to minor changes in plasma levels of T 4 than 
type I and Ill deiodinases. This can be seen as a compensatory mecha- 
nism to maintain a normal tissue T 3 concentration i spite of a fall in 
circulating T4 level. 
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